Last reviewed 2026-05-19 · How we verify

long acting injectable risperidone, High Dose Group

Northwestern University · FDA-approved active Small molecule ✓ Verified May 2026 Quality 1/100

long acting injectable risperidone, High Dose Group is a Small molecule drug developed by Northwestern University. It is currently FDA-approved. Also known as: Risperidone Consta/High Dose.

Long-acting injectable risperidone is used to treat schizophrenia and schizoaffective disorder. It is a high-dose formulation of the medication, which is administered via injection.

At a glance

Generic name	long acting injectable risperidone, High Dose Group
Also known as	Risperidone Consta/High Dose
Sponsor	Northwestern University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

long acting injectable risperidone, High Dose Group CI brief — competitive landscape report
long acting injectable risperidone, High Dose Group updates RSS · CI watch RSS
Northwestern University portfolio CI

Frequently asked questions about long acting injectable risperidone, High Dose Group

What is long acting injectable risperidone, High Dose Group?

long acting injectable risperidone, High Dose Group is a Small molecule drug developed by Northwestern University.

Who makes long acting injectable risperidone, High Dose Group?

long acting injectable risperidone, High Dose Group is developed and marketed by Northwestern University (see full Northwestern University pipeline at /company/northwestern-university).

Is long acting injectable risperidone, High Dose Group also known as anything else?

long acting injectable risperidone, High Dose Group is also known as Risperidone Consta/High Dose.

What development phase is long acting injectable risperidone, High Dose Group in?

long acting injectable risperidone, High Dose Group is FDA-approved (marketed).

Manufacturer: Northwestern University — full pipeline
Also known as: Risperidone Consta/High Dose

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing